VGI Health Technology (XNEC:VTL) Repurchase of Stock : A$0.00 Mil (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Repurchase of Stock?

VGI Health Technology's Repurchase of Stock for the six months ended in . 20 was A$0.00 Mil.

VGI Health Technology's Repurchase of Stock for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

VGI Health Technology Repurchase of Stock Historical Data

The historical data trend for VGI Health Technology's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Repurchase of Stock Chart

VGI Health Technology Annual Data

Trend

Repurchase of Stock

VGI Health Technology Semi-Annual Data

Repurchase of Stock

VGI Health Technology Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Repurchase of Stock for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

VGI Health Technology Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Repurchase of Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines